This is a lightly edited transcript from a recent episode of STAT’s biotech podcast, “The Readout LOUD.” Like it? Consider subscribing to hear every episode.

Over the past decade, more than 25 million people have ordered at-home DNA testing kits from companies like 23andMe and Ancestry.com. You spit in a tube, send it away, and get notified by email when your results are ready. Initially aimed at providing information about ancestry, some companies now test for certain genetic mutations that are strongly correlated with the risk of developing cancer, Alzheimer’s disease, or other serious conditions.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I still would find it very useful to have some links around this article with advice of where one should get BRCA testing. You clearly, very obviously do not want to get your BRCA tested by 23andme, as the article says, but the article doesn’t provide any hint of where one should get it. There are a few direct-to-consumer (=pretty cheap) offers out there, but I have no idea what the differences are and what is recommended by the medical people. Don’t tell me to ask a GP, most of them have idea what genetic testing is about.

  • If I were the editor, I would have asked Dorothy to rewrite the article from this perspective: a 23andme test provided me with the information I needed to save my own life. It is understandable that the news was disturbing but the company does warn users about that. The gift that Dorothy got was huge, but she didn’t seem to acknowledge that first and foremost. It is articles like these that paint companies that provide groundbreaking information at a very low cost direct to the consumer in a bad light – and that is not at all deserved.

Your daily dose of news in health and medicine

Privacy Policy